An In-House Cheat Sheet On Tax Inversion Deals

By Melissa Maleske (November 25, 2015, 2:29 PM EST) -- Following years of increasing popularity among companies seeking to escape the long arm of U.S. taxes, inversion deals are in the hot seat after Pfizer Inc. announced a blockbuster merger with Irish drugmaker Allergan PLC on the tail of the IRS' new attempts to halt the practice. So how did we get here? Here's what you need to know....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!